DK569985A - Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus - Google Patents

Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus Download PDF

Info

Publication number
DK569985A
DK569985A DK569985A DK569985A DK569985A DK 569985 A DK569985 A DK 569985A DK 569985 A DK569985 A DK 569985A DK 569985 A DK569985 A DK 569985A DK 569985 A DK569985 A DK 569985A
Authority
DK
Denmark
Prior art keywords
vaccine
virus
infectious bronchitis
live
priming
Prior art date
Application number
DK569985A
Other languages
English (en)
Other versions
DK170923B1 (da
DK569985D0 (da
Inventor
Philip George Box
Harvey Charles Holmes
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10571022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK569985(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK569985D0 publication Critical patent/DK569985D0/da
Publication of DK569985A publication Critical patent/DK569985A/da
Application granted granted Critical
Publication of DK170923B1 publication Critical patent/DK170923B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK569985A 1984-12-11 1985-12-10 Vaccine mod infektiøst fuglebronkitisvirus, anvendelse af et inaktiveret infektiøst fuglebronkitisvirus til fremstilling heraf samt vaccinesæt DK170923B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848431253A GB8431253D0 (en) 1984-12-11 1984-12-11 Biological preparations
GB8431253 1984-12-11

Publications (3)

Publication Number Publication Date
DK569985D0 DK569985D0 (da) 1985-12-10
DK569985A true DK569985A (da) 1986-06-12
DK170923B1 DK170923B1 (da) 1996-03-18

Family

ID=10571022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569985A DK170923B1 (da) 1984-12-11 1985-12-10 Vaccine mod infektiøst fuglebronkitisvirus, anvendelse af et inaktiveret infektiøst fuglebronkitisvirus til fremstilling heraf samt vaccinesæt

Country Status (7)

Country Link
EP (1) EP0186368B1 (da)
AT (1) ATE62134T1 (da)
DE (1) DE3582422D1 (da)
DK (1) DK170923B1 (da)
GB (1) GB8431253D0 (da)
IE (1) IE58822B1 (da)
ZA (1) ZA859428B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707168B1 (fr) * 1993-07-08 1995-08-18 Rhone Merieux Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif.
DE69426051T2 (de) * 1993-07-30 2001-05-10 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff für Geflügel
WO2001009290A2 (es) * 1999-07-30 2001-02-08 Laboratorio Avi-Mex, S.A. De C.V. Serotipo de virus de bronquitis infecciosa aviar

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines

Also Published As

Publication number Publication date
IE853109L (en) 1986-06-11
DE3582422D1 (de) 1991-05-08
ZA859428B (en) 1987-08-26
EP0186368A2 (en) 1986-07-02
EP0186368B1 (en) 1991-04-03
DK170923B1 (da) 1996-03-18
EP0186368A3 (en) 1987-02-04
GB8431253D0 (en) 1985-01-23
ATE62134T1 (de) 1991-04-15
DK569985D0 (da) 1985-12-10
IE58822B1 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
FI903154A0 (fi) Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
Bennejean et al. Vccination of one‐day‐old chicks against newcastle disease using inactivated oil adjuvant vaccine and/or live vaccine
NZ240538A (en) Avirulent salmonella typhi strains and immunogenic compositions.
HUT65367A (en) Method for the preparation of chicken anaemia agent vaccine
DK569985A (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
DE69333730D1 (de) Impfstoff, der acemannan als adjuvans enthält
HUP0104125A2 (hu) Eljárás szárnyasok intradermális immunizálására inaktivált vakcinákkal
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
RO76563A2 (ro) Procedeu de stabilizare a unui vaccin antiherpetic
NZ243251A (en) Vaccine against marek's disease virus in poultry
Gorshunova et al. Persistence of the vaccinia virus and interferon production in the organs of vaccinated white mice
Jeon et al. Studies on the combined inactivated oil emulsion vaccine of Newcastle disease and avian infectious bronchitis in chickens

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed